Skip to main content

Diagnostic options Β· UAE

Molecular Diagnostics tests in Dubai & UAE

Compare available Molecular Diagnostics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

781

Listed price range

550.00–150,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Molecular Diagnostics test prices

Showing 421–435 of 781 matching tests.

Molecular Diagnostics diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-2299
JAK2 V617F Reflex to JAK2 Exon 12 Mutation Detection Test

This test detects activating mutations in the JAK2 gene, specifically the V617F mutation and, if negative, mutations in Exon 12.

Whole Blood (EDTA) 5 Business Days 1,500.00 AED
View
View test specifications and preparation
What it measures
["JAK2 V617F mutation", "JAK2 Exon 12 mutations"]
Parameters
[{"name": "JAK2 V617F Mutation", "reference_range": "Negative"}, {"name": "JAK2 Exon 12 Mutation", "reference_range": "Negative"}]
Preparation
["No fasting required", "Hydration recommended to facilitate venipuncture"]
Indications
["Diagnosis of Philadelphia-negative myeloproliferative neoplasms", "Evaluation of suspected polycythemia vera", "Evaluation of suspected essential thrombocythemia", "Evaluation of suspected primary myelofibrosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 43399-6 ICD-10: D45, D47.3, D47.4, Z15.89
Clinical summary
This test detects activating mutations in the JAK2 gene, specifically the V617F mutation and, if negative, mutations in Exon 12.
TEST-2335
JAK2 V617F, CALR & MPL Mutation Detection Profile Test

This test identifies specific mutations in the JAK2, CALR, and MPL genes, which are key drivers of Philadelphia-negative myeloproliferative neoplasms.

Peripheral whole blood – EDTA lavender tube 5–7 working days (Sample Mon by 11 AM β†’ Report Saturday) 2,000.00 AED
View
View test specifications and preparation
What it measures
["JAK2 V617F mutation", "CALR mutations", "MPL mutations"]
Parameters
[]
Preparation
["No fasting required.", "Complete Genomics Clinical Information Requisition Form (Form 20).", "Sample must be kept refrigerated at 2–8Β°C and never frozen."]
Indications
["Diagnosis of essential thrombocythemia", "Diagnosis of polycythemia vera", "Diagnosis of primary myelofibrosis", "Risk stratification in MPNs", "Guiding targeted therapy decisions"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 33951-2 ICD-10: D47.1, Z01.818
Clinical summary
This test identifies specific mutations in the JAK2, CALR, and MPL genes, which are key drivers of Philadelphia-negative myeloproliferative neoplasms.
TEST-788
JEV RNA Detection Qualitative Test

This test detects the presence of Japanese encephalitis virus RNA in patient samples.

Whole Blood, Serum, Plasma, Cerebrospinal Fluid (CSF) 24–36 hours 800.00 AED
View
View test specifications and preparation
What it measures
["Japanese encephalitis virus RNA"]
Parameters
[]
Preparation
["No fasting required", "Bring detailed travel history", "Bring vaccination record", "Sign informed consent form"]
Indications
["Suspected Japanese encephalitis infection", "Acute encephalitis symptoms after travel to endemic regions", "Evaluation of neurological symptoms in travelers"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 88555-5 ICD-10: A83.0
Clinical summary
This test detects the presence of Japanese encephalitis virus RNA in patient samples.
TEST-5643
KARS1 Gene Deafness Autosomal Recessive Type 89 Genetic Test

This test identifies mutations in the KARS1 gene associated with autosomal recessive deafness type 89.

Peripheral Blood, Extracted DNA, or FTA Card Dried Blood Spot 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["KARS1 gene mutations", "Pathogenic variants"]
Parameters
[]
Preparation
["Provide detailed clinical history", "Provide genetic counselling-drawn pedigree chart"]
Indications
["Suspected autosomal recessive deafness type 89", "Family history of hereditary hearing loss", "Genetic counseling for hearing loss"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 55303-1 ICD-10: H90.8
Clinical summary
This test identifies mutations in the KARS1 gene associated with autosomal recessive deafness type 89.
TEST-6232
KCNJ11 Gene Genetic Test for Non‑Insulin‑Dependent Diabetes Mellitus (NIDDM)

This test evaluates the KCNJ11 gene for pathogenic variants associated with non-insulin-dependent diabetes mellitus (NIDDM). It identifies genetic factors influencing insulin secre...

Peripheral Whole Blood, Extracted DNA, or Dried Blood Spot (FTA Card) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the KCNJ11 gene", "Genetic predisposition to NIDDM"]
Parameters
[]
Preparation
["No fasting or medication changes are needed", "A pre-test genetic counselling session is recommended"]
Indications
["Individuals with a family history of NIDDM", "Risk stratification for NIDDM", "Personalized lifestyle modification planning", "Pharmacologic intervention planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 54235-8 ICD-10: E11.9
Clinical summary
This test evaluates the KCNJ11 gene for pathogenic variants associated with non-insulin-dependent diabetes mellitus (NIDDM). It identifies genetic factors influencing insulin secretion and beta-cell function.
TEST-4223
KCNQ1 Gene Long QT Syndrome Type 1 Genetic Test

This genetic test identifies pathogenic variants in the KCNQ1 gene associated with Long QT Syndrome Type 1.

Peripheral whole blood (EDTA) or FTA card 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["KCNQ1 gene variants", "Pathogenic mutations", "Copy Number Variants (CNVs)"]
Parameters
[]
Preparation
[]
Indications
["Diagnosis of Long QT Syndrome Type 1", "Family history of Long QT Syndrome Type 1", "Evaluation of unexplained syncope or cardiac events"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 96543-7 ICD-10: I45.81
Clinical summary
This genetic test identifies pathogenic variants in the KCNQ1 gene associated with Long QT Syndrome Type 1.
TEST-3267
KIF23 Gene Congenital Dyserythropoietic Anemia Type III Genetic Test

This test identifies pathogenic mutations in the KIF23 gene associated with Congenital Dyserythropoietic Anemia Type III (CDA III).

Whole Blood (EDTA), Extracted DNA, or FTA Card Blood Spot 21–28 Days 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in KIF23 gene", "Coding exons and flanking intronic regions"]
Parameters
[]
Preparation
["No specific medication or dietary restrictions are needed unless your physician advises otherwise", "Mandatory pre-test genetic counseling session required"]
Indications
["Diagnosis of CDA III", "Family cascade screening", "Carrier detection", "Prenatal counseling"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81200-3 ICD-10: D64.4
Clinical summary
This test identifies pathogenic mutations in the KIF23 gene associated with Congenital Dyserythropoietic Anemia Type III (CDA III).
TEST-2061
KIT Gene Familial Gastrointestinal Stromal Tumor (GIST) Genetic Test

This test analyzes the KIT gene for pathogenic variants associated with hereditary gastrointestinal stromal tumors (GIST). It identifies individuals at increased risk for developin...

Peripheral Whole Blood 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the KIT gene"]
Parameters
[]
Preparation
["Provide a detailed clinical history", "Attend a genetic counseling session to draw a family pedigree chart"]
Indications
["Individuals with a family history of GIST", "Personal history of GIST", "Cascade screening for family members of GIST patients"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 53727-8 ICD-10: Z15.09
Clinical summary
This test analyzes the KIT gene for pathogenic variants associated with hereditary gastrointestinal stromal tumors (GIST). It identifies individuals at increased risk for developing GIST.
TEST-2024
KIT Gene Mutation Analysis for Acute Myeloid Leukemia (Genetic Test)

This genetic test identifies activating mutations within the KIT gene using Next-Generation Sequencing (NGS). It provides critical prognostic and therapeutic guidance for core-bind...

Peripheral whole blood, extracted DNA, or FTA card (dried blood spot) 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["KIT gene activating mutations", "Variant Allele Frequency (VAF)"]
Parameters
[]
Preparation
["Clinical history and genetic counselling session recommended before sample collection"]
Indications
["Diagnosis of core-binding factor acute myeloid leukemia (CBF-AML)", "Risk stratification in AML", "Guidance for tyrosine kinase inhibitor therapy"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21634-8 ICD-10: C92.8, Z15.09, Z80.6
Clinical summary
This genetic test identifies activating mutations within the KIT gene using Next-Generation Sequencing (NGS). It provides critical prognostic and therapeutic guidance for core-binding factor acute myeloid leukemia (CBF-AML).
TEST-4636
KIT Gene Piebaldism Genetic Test

This test analyzes the entire KIT gene using next-generation sequencing to identify pathogenic variants associated with congenital piebaldism.

Peripheral Whole Blood (EDTA), Pre-extracted DNA, or FTA Card 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["KIT gene variants", "Copy Number Variants (CNVs) in KIT gene"]
Parameters
[]
Preparation
["No fasting or special preparation required"]
Indications
["Suspected congenital piebaldism", "Differential diagnosis of pigmentary disorders"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 48018-8 ICD-10: Q82.8, L81.9, Z13.79
Clinical summary
This test analyzes the entire KIT gene using next-generation sequencing to identify pathogenic variants associated with congenital piebaldism.
TEST-3222
KLF1 Gene Lutheran Inhibitor Blood Group Genetic Test

This test identifies genetic variants in the KLF1 gene associated with the Lutheran null phenotype and inhibitor risk.

Whole Blood, FTA Card, or Extracted DNA 3-4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the KLF1 gene", "Lutheran null phenotype risk"]
Parameters
[]
Preparation
["No specific fasting required", "Inform the laboratory of all medications taken, especially anticoagulants or antiplatelet agents"]
Indications
["Patients with antibodies against Lutheran antigens", "Family history of hemolytic disease of the newborn", "Pre-transfusion screening in high-risk individuals"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82939-0 ICD-10: Z13.79, P55.8, Z84.81
Clinical summary
This test identifies genetic variants in the KLF1 gene associated with the Lutheran null phenotype and inhibitor risk.
TEST-6019
KLF11 Gene MODY7 Genetic Test

This test directly sequences the KLF11 gene to detect pathogenic variants causing Maturity-Onset Diabetes of the Young type 7 (MODY7).

Whole Blood (EDTA), Extracted DNA, or FTA Card 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["KLF11 gene coding region", "KLF11 gene splice sites"]
Parameters
[]
Preparation
["List all current medications at booking", "No specific fasting required"]
Indications
["Suspected monogenic diabetes (MODY)", "Differentiation from Type 1/Type 2 diabetes", "Family screening for MODY7"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: E11.8
Clinical summary
This test directly sequences the KLF11 gene to detect pathogenic variants causing Maturity-Onset Diabetes of the Young type 7 (MODY7).
TEST-2330
KRAS & NRAS Mutation Analysis Panel Test

This test identifies somatic mutations in KRAS and NRAS genes within FFPE tumor tissue.

Formalin-Fixed Paraffin-Embedded (FFPE) Tumor Tissue – Archival Specimen Under 7 days (Sample Tue by 11 am; Report Mon) 2,500.00 AED
View
View test specifications and preparation
What it measures
["KRAS gene mutations", "NRAS gene mutations"]
Parameters
[]
Preparation
[]
Indications
["Personalized therapy selection for colorectal cancer", "Personalized therapy selection for lung cancer", "Personalized therapy selection for pancreatic cancer", "Guidance for anti-EGFR therapy"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 91848-0, 91849-8 ICD-10: C18.9, C20, C34.9, C25.9
Clinical summary
This test identifies somatic mutations in KRAS and NRAS genes within FFPE tumor tissue.
TEST-1459
KRAS & NRAS Mutation Panel Test

This test detects mutations in the KRAS and NRAS genes within archival tumor tissue.

Archival Tumor Tissue (FFPE block, biopsy slides, or surgical pathology cuts) 7–8 business days 2,400.00 AED
View
View test specifications and preparation
What it measures
["KRAS gene mutations (codons 12, 13, 61)", "NRAS gene mutations (codons 12, 13, 61)"]
Parameters
[{"name": "KRAS Mutation Status", "reference_range": "Negative (Wild-type)"}, {"name": "NRAS Mutation Status", "reference_range": "Negative (Wild-type)"}]
Preparation
["No patient preparation required as it uses archival tissue."]
Indications
["Eligibility assessment for anti-EGFR therapy in colorectal cancer", "Prognostic information in ovarian and endometrial malignancies"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94774-9 ICD-10: C18.9
Clinical summary
This test detects mutations in the KRAS and NRAS genes within archival tumor tissue.
TEST-2361
KRAS Codon 61 Mutation Detection Test

This test detects mutations in the KRAS gene's codon 61 within tumor tissue.

Tumor Tissue (Fresh in Saline or FFPE Block) 15 Days from sample receipt 1,500.00 AED
View
View test specifications and preparation
What it measures
["KRAS gene mutations", "Codon 61 alterations"]
Parameters
[]
Preparation
[]
Indications
["Colorectal cancer", "Lung cancer", "Pancreatic cancer", "Guidance for targeted therapy"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 44635-8 ICD-10: C18.9
Clinical summary
This test detects mutations in the KRAS gene's codon 61 within tumor tissue.

Category overview

Molecular Diagnostics: overview

When complex health questions arise, evaluating your health at the cellular level provides the definitive clarity necessary for proactive care. At DNA Labs UAE, our Molecular Diagnostics services harness the power of advanced nucleic acid amplification and real-time PCR technologies to detect diseases with unparalleled sensitivity. From identifying viral loads to pinpointing genetic markers, our specialized molecular testing in the UAE gives your healthcare provider the precise data needed to customize your medical strategy. Trust in one of the leading diagnostic labs in Dubai and the UAE to process your samples with rigorous confidentiality and exceptionally fast, accurate turnaround times. Step forward with absolute confidence. View our molecular diagnostics profiles below, request a seamless home sample collection, or contact our specialized team to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area